ciprofloxacin has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 4 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with tendinitis by ciprofloxacin are described." | 4.79 | [Tendinitis due to fluoroquinolones. Description of 2 cases]. ( Collado, A; Hernández, MV; Muñoz-Gómez, J; Peris, P; Sierra, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eslami, F | 1 |
| Mahdavi, M | 1 |
| Babaei, E | 1 |
| Hussen, BM | 1 |
| Mostafavi, H | 1 |
| Shahbazi, A | 1 |
| Hidayat, HJ | 1 |
| Hernández, MV | 1 |
| Peris, P | 1 |
| Sierra, J | 1 |
| Collado, A | 1 |
| Muñoz-Gómez, J | 1 |
| Carlens, S | 1 |
| Ringdén, O | 1 |
| Aschan, J | 1 |
| Hägglund, H | 1 |
| Ljungman, P | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Hahn, T | 1 |
| Shtalrid, M | 1 |
| Berrebi, A | 1 |
| Malach, L | 1 |
| Barak, Y | 1 |
| Rubinstein, E | 1 |
1 review available for ciprofloxacin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
[Tendinitis due to fluoroquinolones. Description of 2 cases].
Topics: Adult; Bone Marrow Transplantation; Ciprofloxacin; Combined Modality Therapy; Female; Humans; Leukem | 1994 |
3 other studies available for ciprofloxacin and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Do | 2020 |
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Cyclophosphamide; Disease- | 1998 |
Interferon alpha-2a and ciprofloxacin synergistically inhibit leukemic cell growth.
Topics: Bone Marrow Cells; Cell Division; Ciprofloxacin; Granulocyte-Macrophage Colony-Stimulating Factor; G | 1992 |